Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CleanSpark Inc (CLSK) vs Vertex Pharmaceuticals Incorporated (VRTX) Price & Performance

CleanSpark IncTrade
Vertex Pharmaceuticals IncorporatedTrade

Price performance (Past 24H)

Key statistics

CleanSpark Inc vs Vertex Pharmaceuticals Incorporated — how do they compare? CleanSpark Inc trades at $11.85 (market cap $2.96B), while Vertex Pharmaceuticals Incorporated trades at $528 (market cap $134.25B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 45.4× CleanSpark Inc's market cap, and Vertex Pharmaceuticals Incorporated is trading nearer its 52-week high, CleanSpark Inc nearer its low. Which is the better fit depends on your goals.

CLSKVRTX
Market Cap
$2.96B$134.25B
Sector
TechnologyHealth
52-Week High
$23.20$529.65
52-Week Low
$8.18$376.62
Enterprise Value
$3.95B$128.37B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CleanSpark Inc

CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.

Read more on CLSK

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Read more on VRTX